Avanzanite

Avanzanite Bioscience improves access to orphan medicines across Europe through innovative commercialization and distribution partnerships, positively impacting patient lives.

Health and bio

Latest funding

Series A · November 18, 2025

Amount not disclosed in a source on record.

Funding history ↓

Website: avanzanite.com.

LinkedIn: linkedin.com.

Category: Health and bio.

Sectors: Advice, Health Care, Pharmaceutical.

Stage: Series A.

Based in: Amsterdam, The Netherlands.

Last round: Nov 18, 2025 · 359 days ago.

On Recent Funding since: Nov 8, 2026.

Signals

Website registeredJun 10, 2020 (6 years old)

Funding rounds

November 18, 2025
Series A · amount undisclosed
Source: fundraisingfox.com
June 10, 2020
Website created

Founders and team

AP
Adam Plich FOUNDER, CEO & EXECUTIVE BOARD MEMBER

source: avanzanite.com
AM
Anant Murthy FOUNDER & BOARD MEMBER

source: avanzanite.com
MB
Mark Bechter Senior Vice President of Medical Affairs

Investors

MMVM Life Science Partners

Companies like Avanzanite

OORGN TechPre Seed · Aug 2026
TTreeline Biosciences$200M Series A · Sep 2025
AActio Biosciences$66M Series B+ · Jun 2025
SSudo Bio$37M Series A · Sep 2022
CCanal BiosciencesSeed · Apr 2026
VVoitheia BioScienceSeed · Mar 2026

Sources and API

Every amount links to the page it came from. * Estimated from an accelerator's published standard deal, not a company-specific disclosure. How Recent Funding sources and verifies funding data. The same data as JSON: /api/v1/companies/avanzanite (get a free API key).